Alendronate Sodium
NDC 54868-5861
Product Information
Alendronate Sodium is a ANDA-approved product labeled by Physicians Total Care, Inc.. Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. It is supplied as a white product. This product entry covers the primary NDC 54868-5861 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
SQUARE (C48350)
7 MM
93;5141
93;5172
93;5171
Code Structure Chart
Product Details
What is NDC 54868-5861?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ALENDRONATE SODIUM (UNII: 2UY4M2U3RA)
- ALENDRONIC ACID (UNII: X1J18R4W8P) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 904396 - alendronate sodium 35 MG Oral Tablet
- RxCUI: 904396 - alendronic acid 35 MG Oral Tablet
- RxCUI: 904396 - alendronic acid 35 MG (as alendronate sodium 45.7 MG) Oral Tablet
- RxCUI: 904419 - alendronate sodium 10 MG Oral Tablet
- RxCUI: 904419 - alendronic acid 10 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.